Comparison · NCT00886262-8d8ae8ce
Vasopressin vs Normal Saline Placebo: Count of Patient Who Need Vasopressers in the Perioperative Period
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Vasopressin vs Normal Saline Placebo: Count of Patient Who Need Vasopressers in the Perioperative Period. Trial comparisons, record NCT00886262-8d8ae8ce. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00886262-8d8ae8ce
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.375 | 0.137 | 0.694 | wilson | |
| Risk in group 2 | 0.4 | 0.168 | 0.687 | wilson | |
| Risk difference, group 1 minus group 2 | -0.025 | -0.398 | 0.37 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.938 | 0.29 | 3.03 | log | |
| Odds ratio, group 1 over group 2 | 0.9 | 0.133 | 6.08 | log | |
| Number needed to treat, for one fewer participant with the outcome on Vasopressin than on Normal Saline Placebo | 40 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Vasopressin | Vasopressin: Patients randomly assigned to the experimental arm of the study will receive vasopressin 0.5U/hr IV (20 U vasopressin in 250mL of 0.9% NaCL to infuse at a rate of 6.25mL/hr) via internal jugular catheter. Vasopressin infusion is started at the time of incision and is stopped at the time abdominal closure is completed | 3 | 8 | OG000 |
| Group 2 | Normal Saline Placebo | Normal saline placebo: Patients randomly assigned to the placebo arm of the study will receive placebo (0.9% NaCl to infuse at a rate of 6.25 mL/hr) via internal jugular catheter | 4 | 10 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Count of Patient Who Need Vasopressers in the Perioperative Period
- Description
- Time frame
- 48 hours
- Population
Source ClinicalTrials.gov
Trial
- Title
- Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant
- NCT number
- NCT00886262
- Phases
- NA
- Conditions
- Liver Failure
- Interventions
- Vasopressin, Normal saline placebo
- Lead sponsor
- Medical University of South Carolina
- Results first posted
- 2018-10-17
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT00886262?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT00886262-8d8ae8ce